Strategic Wealth Advisors Group, LLC Editas Medicine, Inc. Transaction History

Strategic Wealth Advisors Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$26.55 - $40.57 $862,158 - $1.32 Million	-32,473 Closed	0 $0
Q3 2021 Nov 17, 2021	SELL	$39.27 - $72.94 $24,897 - $46,243	-634 Reduced 1.92%	32,473 $1.33 Million
Q2 2021 Aug 10, 2021	BUY	$31.29 - $56.64 $80,853 - $146,357	2,584 Added 8.47%	33,107 $1.88 Million
Q1 2021 May 07, 2021	BUY	$39.71 - $90.58 $62,185 - $141,848	1,566 Added 5.41%	30,523 $1.28 Million
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $783,865 - $2.44 Million	28,957 New	28,957 $2.03 Million

247

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $166M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.